The Pharma Data

OCTOBER 21, 2020

21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. The disease is a subtype of ALL in which the cancer cells have a genetic abnormality called the Philadelphia chromosome (Ph). WEDNESDAY, Oct.

Drugs 52

Drugs Genetics Trials Research 52

The Pharma Data

OCTOBER 21, 2020

21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. The disease is a subtype of ALL in which the cancer cells have a genetic abnormality called the Philadelphia chromosome (Ph). WEDNESDAY, Oct.

Drugs 52

Drugs Genetics Trials Research 52

pharmaphorum

AUGUST 10, 2020

Evrysdi is the third treatment approved for SMA , an ultra-rare muscle wasting disease that can begin in early childhood, after Biogen’s Spinraza (nusinersen) and Novartis’ Zolgensma (onasemnogene abeparvovec). Evrysdi also improved survival without permanent ventilation at 12 and 23 months, compared to natural history.

FDA Approval 59

FDA Approval Drugs Gene Therapy Protein 59

XTalks

APRIL 29, 2022

Tirzepatide was previously shown to reduce weight in diabetic individuals, and now, results from Lilly’s trial exclusive to obesity show that it can help people without diabetes lose significant pounds. Wegovy had a price tag of $1,297 a month when it was first launched. percent and 22.5 percent, respectively, compared to placebo.

Trials 98

Trials Drugs FDA Approval Clinical Trials 98

pharmaphorum

NOVEMBER 28, 2022

Owkin is simultaneously releasing two other open-source projects: FLamby, a federated learning model-ready dataset that researchers can use to develop models before training them on other data sets, and SecureFedYJ, a tool for normalising real-world healthcare data while maintaining data privacy.

Pharma Companies 72

Pharma Companies Life Science Research Development 72

XTalks

DECEMBER 21, 2022

As the world continues to experience the effects and aftermath of the COVID-19 pandemic, lessons learned from the biggest global health crisis in recent times spurred changes and adaptations in the life sciences and healthcare. There is also generally a low cost of return for gene therapies, particularly those for rare diseases.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

The Pharma Data

MAY 15, 2021

Whatever you do, if you care about your health and freedom, don’t miss out on this opportunity to discover what might be the best weight loss and longevity solution in world history. Water-resistant, dustproof, rainproof, anti-sweat, and easy hand-washing and bathing without removal. Or click “Continue Reading” to return to the letter.

Production 52

Production Containment Medicine Vaccination 52

XTalks

FEBRUARY 11, 2021

However, World War II developments led to a change in plans, leading her to serve as a London air raid warden. It still remains unclear whether Franklin’s work was accessed and interpreted with or without rightful permissions. Franklin studied physical chemistry at Newnham College, University of Cambridge, graduating in 1941.

Genetics 119

Genetics DNA Genome Genomics 119

The Pharma Data

MAY 4, 2021

In addition, we have achieved important clinical, regulatory and commercial milestones across our pipeline and portfolio while also continuing to increase our capacity to supply urgently-needed doses of BNT162b2 to the world. Rare Disease. Internal Medicine. Inflammation & Immunology. Total Revenue. 42%. . . . . .

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

NOVEMBER 30, 2022

In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246